FDPS anticorps
Aperçu rapide pour FDPS anticorps (ABIN7091096)
Antigène
Voir toutes FDPS AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Homologie
- Human,Mouse
-
Immunogène
- Recombinant human FDPS.
-
-
-
-
Indications d'application
- WB 1:300-5000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Date de péremption
- 12 months
-
-
- FDPS (Farnesyl Diphosphate Synthase (FDPS))
-
Autre désignation
- FDPS
-
Sujet
-
Synonyms: FPPS_HUMAN, Farnesyl pyrophosphate synthase, FPP synthase, FPS, (2E,6E)-farnesyl diphosphate synthase, Dimethylallyltranstransferase, Farnesyl diphosphate synthase, Geranyltranstransferase.
Background: Key enzyme in isoprenoid biosynthesis which catalyzes the formation of farnesyl diphosphate (FPP), a precursor for several classes of essential metabolites including sterols, dolichols, carotenoids, and ubiquinones. FPP also serves as substrate for protein farnesylation and geranylgeranylation. Catalyzes the sequential condensation of isopentenyl pyrophosphate with the allylic pyrophosphates, dimethylallyl pyrophosphate, and then with the resultant geranylpyrophosphate to the ultimate product farnesyl pyrophosphate.
-
ID gène
- 2224
-
UniProt
- P14324
-
Pathways
- Regulation of Muscle Cell Differentiation
Antigène
-